P2X receptors as a therapeutic opportunity

Acronym: PRESTO

Principal investigator: for IVN Carmen C. Diaconu, PhD

(2022-2026; EU- COST, COST CA21130) – Principal investigator: for IVN Carmen C. Diaconu, PhD